Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for prevention of atrial fibrillation after open heart surgery
NCT03021343Phase 3Completed
- Sponsor
- Jordan Collaborating Cardiology Group
- Start
- Oct 2012
- Primary completion
- Jan 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, open-label trial of colchicine in Atrial fibrillation (AFib), sponsored by Jordan Collaborating Cardiology Group. Primary endpoints: Number of Participants With Atrial Fibrillation at 2 weeks and Number of Participants With Colchicine Side Effects at 2 weeks. Started Oct 2012; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03021343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03021343.